P03369 (POL_HV1A2) Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)(HIV-1)
Gag-Pol polyprotein UniProtKBInterProInteractive Modelling
1437 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
121 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… |
Heteromer | 2×ACT; | ||||
| Assess | ||||||
| Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate … |
Heteromer Q9YP46; | 1×BME; 3×EDO; 3×GOL; 1×ACT; 1×PO4; | ||||
| Assess | ||||||
| Crystal Structure of inactive single chain variant of HIV-1 Protease in Complex with the substrate … |
Heteromer Q9YV20; | 6×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate p… |
Heteromer Q9YP46; | 2×GOL; 1×EDO; 1×DMS; 1×ACT; 1×BME; | ||||
| Assess | ||||||
| Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate C… |
Heteromer Q9YP46; | 3×GOL; 1×BME; | ||||
| Assess | ||||||
| Crystal Structure of inactive single chain wild-type HIV-1 Protease in Complex with the substrate R… |
Heteromer Q9YV20; | 1×GOL; 1×PO4; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate va… |
Heteromer P03349; | 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (P453L) |
Heteromer P03349; | 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease in complex with the P1-P6 substrate variant (L449F/S45… |
Heteromer P03349; | 3×GOL; 1×EDO; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate va… |
Heteromer P03349; | 1×PO4; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease Variant (D30N/N88D) in Complex w… |
Heteromer P03349; | 2×GOL; 5×EDO; 1×PO4; 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (S451N) |
Heteromer P03349; | 3×GOL; 3×ACT; 6×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the … |
Heteromer P04591; | 2×GOL; 1×PO4; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease in complex with p1-p6 substrate variant (R452S) |
Heteromer P03349; | 4×PO4; 5×GOL; | ||||
| Assess | ||||||
| Crystal Structure of Inactive HIV-1 Protease in Complex with the p1-p6 substrate variant (L449F) |
Heteromer P03349; | 4×GOL; 6×EDO; | ||||
| Assess | ||||||
| Crystal Structure of Nelfinavir-Resistant, Inactive HIV-1 Protease (D30N/N88D) in Complex with the … |
Heteromer P03349; | 1×GOL; 2×EDO; | ||||
| Assess | ||||||
| Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral thera… |
Heteromer Q9YYH6; | 6×ACT; | ||||
| Assess | ||||||
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… |
Heteromer P03366; | 2×ACT; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-… |
Heteromer P04591; | 10×ACT; | ||||
| Assess | ||||||
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… |
Heteromer P20875; | 5×ACT; | ||||
| Assess | ||||||
| HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. |
Heteromer Q9YX54; | 6×ACT; | ||||
| Assess | ||||||
| Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6 substrate va… |
Heteromer P03349; | 3×GOL; 1×PO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE V… |
Heteromer P04591; | |||||
| Assess | ||||||
| Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral thera… |
Heteromer Q9YX54; | 3×ACT; | ||||
| Assess | ||||||
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… |
Heteromer P20875; | 7×ACT; | ||||
| Assess | ||||||
| Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [l-ala51,d-ala51'] hi… | homo-2-mer | |||||
| Assess | ||||||
| Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibit… | homo-2-mer | 3×SO4; 2×GOL; 1×ACT; | ||||
| Assess | ||||||
| Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease in complex with JG-365 | homo-2-mer | 4×ACT; 3×GOL; 5×SO4; | ||||
| Assess | ||||||
| JE-2147-HIV Protease Complex | homo-2-mer | 1×JE2; 5×CL; 5×EDO; | ||||
| Assess | ||||||
| HIV protease wild-type in complex with TMC114 inhibitor | homo-2-mer | 5×PO4; 1×017; | ||||
| Assess | ||||||
| Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed with Inhibit… | homo-2-mer | 1×2NC; 5×SO4; 5×ACT; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V var… | homo-2-mer | 3×ACT; 6×PO4; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV-1 Protease in complex with af61 | homo-2-mer | 4×PO4; 1×A61; | ||||
| Assess | ||||||
| X-ray structure of ester chemical analogue [O-Gly51,O-Gly51']HIV-1 protease complexed with MVT-101 … | homo-2-mer | 1×2NC; 3×SO4; | ||||
| Assess | ||||||
| X-ray structure of ester chemical analogue [O-Ile50,O-Ile50']HIV-1 protease complexed with MVT-101 | homo-2-mer | 1×2NC; | ||||
| Assess | ||||||
| X-ray crystal structure of HIV-1 Protease T80N variant in complex with the inhibitor saquinavir use… | homo-2-mer | 7×PO4; 1×QNC; 1×ASN; 1×HPH; 1×DIQ; 1×NTB; | ||||
| Assess | ||||||
| Crystal structure of nelfinavir (NFV) complexed with a multidrug variant (ACT) (V82T/I84V) of HIV-1… | homo-2-mer | 11×ACT; 1×1UN; | ||||
| Assess | ||||||
| Crystal structure of atazanavir (ATV) in complex with a multidrug HIV-1 protease (V82T/I84V) | homo-2-mer | 1×DR7; 1×ACT; 6×PO4; | ||||
| Assess | ||||||
| Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease.… | homo-2-mer | 3×SO4; 2×DRS; | ||||
| Assess | ||||||
| Crystal Structures Of Highly Constrained Substrate And Hydrolysis Products Bound To HIV-1 Protease.… | homo-2-mer | 4×SO4; 1×DRR; | ||||
| Assess | ||||||
| Crystal structure of the inhibitor Atazanavir (ATV) in complex with a multi-drug resistance HIV-1 p… | homo-2-mer | 3×PO4; 1×DR7; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Atazanavir | homo-2-mer | 3×GOL; 2×EDO; 3×ACT; 1×DR7; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV-1 Protease in complex with af53 | homo-2-mer | 3×PO4; 1×F53; | ||||
| Assess | ||||||
| Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate … | homo-2-mer | 1×GOL; 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV-1 Protease in complex with kd27 | homo-2-mer | 1×K2D; 3×ACT; 1×PO4; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV-1 Protease in complex with kd26 | homo-2-mer | 4×PO4; 1×ACT; 1×K2E; | ||||
| Assess | ||||||
| Co-crystal structure of HIV-1 protease bound to a mutant resistant inhibitor UIC-98038 | homo-2-mer | 1×DJR; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir | homo-2-mer | 1×DR7; 3×ACT; | ||||
| Assess | ||||||
| Crystal structure of the wild type HIV-1 protease with the inhibitor, Amprenavir | homo-2-mer | 1×478; 4×ACT; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 I50V, A71 Protease in Complex with the protease inhibitor amprenavir. | homo-2-mer | 2×478; 1×PO4; 1×GOL; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR | homo-2-mer | 3×SO4; 1×PI6; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR | homo-2-mer | 3×SO4; 1×PI9; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4 | homo-2-mer | 3×SO4; 1×PI4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 L76V Protease in Complex with the Protease Inhibitor Darunavir. | homo-2-mer | 4×PO4; 7×ACT; 1×017; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-2-AD93 in complex with wild type HIV-1 protease | homo-2-mer | 1×PO4; 1×MZ6; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease | homo-2-mer | 1×K62; 1×PO4; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV protease in complex with the inhibitor, Atazanavir | homo-2-mer | 1×DR7; 4×PO4; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, AD78 in complex with wild type HIV-1 protease | homo-2-mer | 1×D78; 3×PO4; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 | homo-2-mer | 3×SO4; | ||||
| Assess | ||||||
| HIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 3 | homo-2-mer | 4×SO4; 1×HBB; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-2-AD86 in complex with wild type HIV-1 protease | homo-2-mer | 2×PO4; 3×ACT; 1×MZ9; | ||||
| Assess | ||||||
| HIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2 | homo-2-mer | 3×SO4; 1×HBH; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, KB60 in complex with wild type HIV-1 protease | homo-2-mer | 1×K60; 2×PO4; 2×ACT; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 protease inhibitor, KC32 complexed with wild-type protease | homo-2-mer | 1×K54; 1×PO4; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-2-KC08 in complex with wild type HIV-1 protease | homo-2-mer | 3×PO4; 1×MZ7; | ||||
| Assess | ||||||
| Crystal Structure of protease inhibitor, MIT-1-AC86 in complex with wild type HIV-1 protease | homo-2-mer | 4×PO4; 4×ACT; 1×MZ1; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-2-KB98 in complex with wild type HIV-1 protease | homo-2-mer | 2×PO4; 1×MZ8; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-1-AC87 in complex with wild type HIV-1 protease | homo-2-mer | 5×PO4; 1×MZ2; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR | homo-2-mer | 2×SO4; 1×PI8; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6 | homo-2-mer | 3×SO4; 1×PI6; | ||||
| Assess | ||||||
| Crystal Structure of the active HIV-1 Protease in Complex with the products of p1-p6 substrate | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5 | homo-2-mer | 3×SO4; 1×PI5; | ||||
| Assess | ||||||
| Crystal structure of wild-type inactive (D25N) HIV-1 protease complexed with wild-type HIV-1 NC-p1 … | homo-2-mer | 2×ACT; 1×PO4; | ||||
| Assess | ||||||
| X-ray structure of ester chemical analogue [O-Ile50,O-Ile50']HIV-1 protease complexed with KVS-1 in… | homo-2-mer | 5×SO4; 1×KVS; | ||||
| Assess | ||||||
| Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of CA-p2 cleavage… | homo-2-mer | 1×ACT; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of Wild-type HIV-1 Protease in Complex With TMC310911 | homo-2-mer | 1×74T; 1×PO4; | ||||
| Assess | ||||||
| STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE… | homo-2-mer | 2×CL; 2×THK; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 I50V, A71V Protease in Complex with the Protease Inhibitor Darunavir | homo-2-mer | 1×017; 2×PO4; 3×ACT; 2×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-2-AD94 in complex with wild type HIV-1 protease | homo-2-mer | 2×PO4; 1×MZ5; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 protease inhibitor KC53 in complex with wild-type protease | homo-2-mer | 1×K53; 4×PO4; 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of the inhibitor Darunavir (DRV) in complex with a multi-drug resistant HIV-1 pro… | homo-2-mer | 3×ACT; 1×017; | ||||
| Assess | ||||||
| Crystal structure of the wild-type HIV-1 protease with the inhibitor, Nelfinavir | homo-2-mer | 1×1UN; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of the inhibitor Nelfinavir (NFV) in complex with a multi-drug resistant HIV-1 pr… | homo-2-mer | 1×1UN; 2×PO4; 5×ACT; | ||||
| Assess | ||||||
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… | homo-2-mer | 4×ACT; | ||||
| Assess | ||||||
| Crystal structure of inhibitor saquinavir (SQV) complexed with the multidrug HIV-1 protease variant… | homo-2-mer | 1×ROC; 2×ACT; | ||||
| Assess | ||||||
| Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral thera… | homo-2-mer | 6×PO4; | ||||
| Assess | ||||||
| Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-… | homo-2-mer | 2×PO4; | ||||
| Assess | ||||||
| X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir use… | homo-2-mer | 5×PO4; 1×QNC; 1×ASN; 1×HPH; 1×DIQ; 1×NTB; | ||||
| Assess | ||||||
| Structure of HIV-1 protease D25N complexed with rt-rh analogue peptide GLY-ALA-ASP-ILE-PHE*TYR-LEU-… | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Wa… | homo-2-mer | 2×PO4; 3×ACT; 1×MUW; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-1-KK81 in complex with wild type HIV-1 protease | homo-2-mer | 4×PO4; 1×MZ4; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 | homo-2-mer | 3×SO4; 1×PI7; | ||||
| Assess | ||||||
| REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES. DESIGN OF HYDROLYTICALLY STABLE CYCLI… | homo-2-mer | 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of protease inhibitor, MIT-1-KK80 in complex with wild type HIV-1 protease | homo-2-mer | 1×PO4; 1×MZ3; | ||||
| Assess | ||||||
| Crystal structure of atazanavir (ATV) in complex with I50L/A71V drug-resistant HIV-1 protease | homo-2-mer | 1×DR7; 4×PO4; | ||||
| Assess | ||||||
| Crystal structure of I50L/A71V mutant of hiv-1 protease in complex with inhibitor darunavir | homo-2-mer | 1×017; 5×PO4; 3×ACT; | ||||
| Assess | ||||||
| Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug resistant HIV-1 pr… | homo-2-mer | 4×PO4; 6×ACT; 1×478; | ||||
| Assess | ||||||
| Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir. | homo-2-mer | 1×017; 5×PO4; 3×ACT; | ||||
| Assess | ||||||
| Crystal Structure of active HIV-1 Protease in Complex with the N terminal product of the substrate … | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of inhibitor saquinavir (SQV) in complex with multi-drug resistant HIV-1 protease… | homo-2-mer | 1×ROC; 2×PO4; | ||||
| Assess | ||||||
| SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | homo-2-mer | |||||
| Assess | ||||||
| STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE… | homo-2-mer | 1×CL; 1×THK; | ||||
| Assess | ||||||
| Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral The… | homo-2-mer | 1×RIT; | ||||
| Assess | ||||||
| Crystal structure of amprenavir (APV) in complex with a drug resistant HIV-1 protease variant (I50L… | homo-2-mer | 4×ACT; 1×478; | ||||
| Assess | ||||||
| Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-… | homo-2-mer | |||||
| Assess | ||||||
| Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Angstroms … | homo-2-mer | 1×2NC; | ||||
| Assess | ||||||
| SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | homo-2-mer | |||||
| Assess | ||||||
| X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENC… | homo-2-mer | |||||
| Assess | ||||||
| Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral thera… | homo-2-mer | 1×QNC; 1×ASN; 1×HPH; 1×DIQ; 1×NTB; | ||||
| Assess | ||||||
| STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1… | homo-2-mer | |||||
| Assess | ||||||
| A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SY… | homo-2-mer | 1×ARQ; | ||||
| Assess | ||||||
| CONSERVED FOLDING IN RETROVIRAL PROTEASES. CRYSTAL STRUCTURE OF A SYNTHETIC HIV-1 PROTEASE | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of chemically synthesized 203 amino acid 'covalent dimer' [L-Ala;Gly51']HIV-1 pro… | monomer | 1×2NC; | ||||
| Assess | ||||||
| Crystal structure of chemically synthesized 'covalent dimer' [Gly51/D-Ala51']HIV-1 protease | monomer | 1×2NC; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-Ala51,D-Ala51'] HI… | monomer | 1×2NC; | ||||
| Assess | ||||||
| Crystal structure of a chemically synthesized 203 amino acid 'covalent dimer' [Gly51;Aib51']HIV-1 p… | monomer | 1×2NC; 1×SO4; | ||||
| Assess | ||||||
| X-ray structure of ester chemical analogue 'covalent dimer' [Ile50,O-Ile50']HIV-1 protease complexe… | monomer | 1×KVS; 4×SO4; | ||||
| Assess | ||||||
| Crystal structure of chemically synthesized HIV-1 protease with reduced isostere MVT-101 inhibitor | monomer | 1×2NC; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of [L-Ala51/51']HIV-1 protease with reduced isostere MVT-101 inhibitor | monomer | |||||
| Assess | ||||||
| Crystal structure of chemically synthesized [D-Ala51/51']HIV-1 protease | monomer | 1×2NC; | ||||
| Assess | ||||||
| Crystal structure of chemically synthesized [Aib51/51']HIV-1 protease | monomer | |||||
| Assess | ||||||
8 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6rwm.1.A | homo-12-mer | 0.75 | 8×ZN; | 74.65 | ||
| Assess | ||||||
| 6rwl.1.B | monomer | 0.73 | 1×ZN; | 74.65 | ||
| Assess | ||||||
| 6rwl.1.A | monomer | 0.73 | 1×ZN; | 74.65 | ||
| Assess | ||||||
| 6v3k.3.A | homo-4-mer | 0.72 | 93.61 | |||
| Assess | ||||||
| 7t15.1.E | homo-6-mer | 0.70 | 84.85 | |||
| Assess | ||||||
| 7sep.1.A | homo-2-mer | 0.70 | 95.77 | |||
| Assess | ||||||
| 1l6n.1.A | monomer | 0.69 | 97.17 | |||
| Assess | ||||||
| 7asl.1.A | homo-18-mer | 0.66 | 98.30 | |||
| Assess | ||||||